Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017–2019

  • Thanh Vu Nguyen
    Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan
  • Mya Myat Ngwe Tun
    Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan
  • Minh Thang Cao
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Huy Manh Dao
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Chan Quang Luong
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Thi Kim Loan Huynh
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Thi Thanh Thuong Nguyen
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Thi Nhu Dao Hoang
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Kouichi Morita
    Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan
  • Thi Quynh Mai Le
    National Institute of Hygiene and Epidemiology, Hanoi 100000, Vietnam
  • Quang Duy Pham
    Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
  • Yuki Takamatsu
    Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan
  • Futoshi Hasebe
    Vietnam Research Station, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan

書誌事項

公開日
2023-10-08
資源種別
journal article
権利情報
  • https://creativecommons.org/licenses/by/4.0/
DOI
  • 10.3390/v15102065
公開者
MDPI AG

説明

<jats:p>Chikungunya fever is an acute febrile illness caused by the chikungunya virus (CHIKV), which is transmitted by Aedes mosquitoes. Since 1965, only a few studies with limited scope have been conducted on CHIKV in Vietnam. Thus, this study aimed to determine the seroprevalence and molecular epidemiology of CHIKV infection among febrile patients in Vietnam from 2017 to 2019. A total of 1063 serum samples from 31 provinces were collected and tested for anti-CHIKV IgM and IgG ELISA. The 50% focus reduction neutralization test (FRNT50) was used to confirm CHIKV-neutralizing antibodies. Quantitative real-time RT–PCR (RT–qPCR) was performed to confirm the presence of the CHIKV genome. The results showed that 15.9% (169/1063) of the patients had anti-CHIKV IgM antibodies, 20.1% (214/1063) had anti-CHIKV IgG antibodies, 10.4% (111/1063) had CHIKV-neutralizing antibodies, and 27.7% (130/469) of the samples were positive in RT–qPCR analysis. The E1 CHIKV genome sequences were detected among the positive RT–qPCR samples. Our identified sequences belonged to the East/Central/South/African (ECSA) genotype, which has been prevalent in Vietnam previously, suggesting CHIKV has been maintained and is endemic in Vietnam. This study demonstrates a high prevalence of CHIKV infection in Vietnam and calls for an annual surveillance program to understand its impact.</jats:p>

収録刊行物

  • Viruses

    Viruses 15 (10), 2065-, 2023-10-08

    MDPI AG

被引用文献 (2)*注記

もっと見る

参考文献 (67)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ